Abstract
The surgical model of destabilization of the medial meniscus (DMM) has become a gold standard for studying the onset and progression of posttraumatic osteoarthritis (OA). The DMM model mimics clinical meniscal injury, a known predisposing factor for the development of human OA, and permits the study of structural and biological changes over the course of the disease. In addition, when applied to genetically modified or engineered mouse models, this surgical procedure permits dissection of the relative contribution of a given gene to OA initiation and/or progression. This chapter describes the requirements for the surgical induction of OA in mouse models, and provides guidelines and tools for the subsequent histological, immunohistochemical, and molecular analyses. Methods for the assessment of the contributions of selected genes in genetically modified strains are also provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Poulet B, Ulici V, Stone TC et al (2012) Time-series transcriptional profiling yields new perspectives on susceptibility to murine osteoarthritis. Arthritis Rheum 64:3256–3266
Poulet B, Hamilton RW, Shefelbine S et al (2011) Characterizing a novel and adjustable noninvasive murine joint loading model. Arthritis Rheum 63:137–147
Ko FC, Dragomir C, Plumb DA et al (2013) In vivo cyclic compression causes cartilage degeneration and subchondral bone changes in mouse tibiae. Arthritis Rheum 65:1569–1578
Sato T, Konomi K, Yamasaki S et al (2006) Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage. Arthritis Rheum 54:808–817
Aigner T, Fundel K, Saas J et al (2006) Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 54: 3533–3544
Glasson SS (2007) In vivo osteoarthritis target validation utilizing genetically-modified mice. Curr Drug Targets 8:367–376
Little CB, Fosang AJ (2010) Is cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis–insights from studies of aggrecan and collagen proteolysis? Curr Drug Targets 11:561–575
Bernardo BC, Belluoccio D, Rowley L et al (2011) Cartilage intermediate layer protein 2 (CILP-2) is expressed in articular and meniscal cartilage and down-regulated in experimental osteoarthritis. J Biol Chem 286:37758–37767
Yasuhara R, Ohta Y, Yuasa T et al (2011) Roles of beta-catenin signaling in phenotypic expression and proliferation of articular cartilage superficial zone cells. Lab Invest 91:1739–1752
Lodewyckx L, Cailotto F, Thysen S et al (2012) Tight regulation of wingless-type signaling in the articular cartilage - subchondral bone biomechanical unit: transcriptomics in Frzb-knockout mice. Arthritis Res Ther 14:R16
Loeser RF, Olex AL, McNulty MA et al (2012) Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum 64:705–717
Nuka S, Zhou W, Henry SP et al (2010) Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice. Osteoarthritis Cartilage 18: 88–96
Glasson SS, Askew R, Sheppard B et al (2005) Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434:644–648
Stanton H, Rogerson FM, East CJ et al (2005) ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434: 648–652
Little CB, Barai A, Burkhardt D et al (2009) Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 60:3723–3733
Echtermeyer F, Bertrand J, Dreier R et al (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 15:1072–1076
Lin AC, Seeto BL, Bartoszko JM et al (2009) Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15: 1421–1425
Sampson ER, Hilton MJ, Tian Y et al (2011) Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med 3:101ra193
Chockalingam PS, Sun W, Rivera-Bermudez MA et al (2011) Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor. Osteoarthritis Cartilage 19:315–323
Johnson K, Zhu S, Tremblay MS et al (2012) A stem cell-based approach to cartilage repair. Science 336:717–721
Rai MF, Hashimoto S, Johnson EE et al (2012) Heritability of articular cartilage regeneration and its association with ear-wound healing. Arthritis Rheum 64:2300–2310
Hashimoto S, Rai MF, Janiszak KL et al (2012) Cartilage and bone changes during development of post-traumatic osteoarthritis in selected LGXSM recombinant inbred mice. Osteoarthritis Cartilage 20:562–571
Nakamura E, Nguyen MT, Mackem S (2006) Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton. Dev Dyn 235: 2603–2612
Dao DY, Jonason JH, Zhang Y et al (2012) Cartilage-specific beta-catenin signaling regulates chondrocyte maturation, generation of ossification centers, and perichondrial bone formation during skeletal development. J Bone Miner Res 27:1680–1694
Henry SP, Jang CW, Deng JM et al (2009) Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage. Genesis 47:805–814
Henry SP, Liang S, Akdemir KC et al (2012) The postnatal role of Sox9 in cartilage. J Bone Miner Res 27:2511–2525
Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89:5547–5551
Grover J, Roughley PJ (2006) Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration. Matrix Biol 25:158–165
Xu L, Polur I, Servais JM et al (2011) Intact pericellular matrix of articular cartilage is required for unactivated discoidin domain receptor 2 in the mouse model. Am J Pathol 179:1338–1346
Glasson SS, Blanchet TJ, Morris EA (2007) The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 15:1061–1069
Flecknell PA (1996) Laboratory animal anesthesia. Academic, London
Glasson SS, Chambers MG, Van Den Berg WB et al (2010) The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 18(Suppl 3):S17–S23
Loeser RF, Olex AL, McNulty MA et al (2013) Disease progression and phasic changes in gene expression in a mouse model of osteoarthritis. PLoS One 8:e54633
Jenkins WL (1987) Pharmacologic aspects of analgesic drugs in animals: an overview. J Am Vet Med Assoc 191:1231–1240
Acknowledgements
Research related to this topic is supported by National Institutes of Health grants R01-AG-022021 and RC4-AR060546.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media. New York
About this protocol
Cite this protocol
Culley, K.L. et al. (2015). Mouse Models of Osteoarthritis: Surgical Model of Posttraumatic Osteoarthritis Induced by Destabilization of the Medial Meniscus. In: Westendorf, J., van Wijnen, A. (eds) Osteoporosis and Osteoarthritis. Methods in Molecular Biology, vol 1226. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1619-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1619-1_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1618-4
Online ISBN: 978-1-4939-1619-1
eBook Packages: Springer Protocols